NCT01236014View on ClinicalTrials.gov

Indirect Comparison Between Eltrombopag & Romiplostim

CompletedOBSERVATIONAL

Enrollment

1

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Thrombocytopaenia

Interventions

DRUG

Eltrombopag

Eltrombopag \& standard of care

DRUG

Romiplostim

Romiplostim \& standard of care

DRUG

Placebo

Placebo \& standard of care

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01236014 - Indirect Comparison Between Eltrombopag & Romiplostim | Biotech Hunter | Biotech Hunter